PET scans with the [11C]ABP688 tracer have consistently shown lower mGluR5 receptor binding in depressed patients, a finding that correlates with the severity of depression (associated with mGluR5 binding in the hippocampus) and is supported by western blot analyses of postmortem brain samples. Here, GRM5 is linked to depressive symptom measurement.